References
Altmayer P, Mayer D, Mayersbach H, Lucker P, Rindt W, et al. Circadian variations in pharmacokinetic parameters after oral application of hexobarbital. Chronobiologia 6: 73, 1979
Angeli A, Argrimonti F, Bertello PD, Frairia R, Vioino PL, et al. Circadian pattern of plasma cortisol and testosterone in chronic male alcoholics. Chronobiologia 9: 115–122, 1982
Aranda JV, Sitar DS, Parsons WD, Loughnan PM, Neims AH. Pharmacokinetic aspects of theophylline in premature newborns. New England Journal of Medicine 295: 413–416, 1976
Aymard N, Soulairac A. Chronobiological changes in pharmacokinetics of dipotassic clorazepate, a benzodiazepine. In Reinberg & Halbcrg (Eds) Chronopharmacology. pp. 111–116. Pergamon Press. Oxford. 1979
Belanger PM, Labrecque G, Dore F. Rate limiting steps in the temporal variations in the metabolism of selected drugs. International Journal of Chronobiology 7: 15, 1981
Besunder JB, Reed MD, Blumer JL. Principles of drug biodisposition in the neonate: a critical evaluation of the pharmacokinetic-pharmacodynamic interface (part I). Clinical Pharmacokinetics 14: 189–216, 1988a
Besunder JB, Reed MD, Blumer JL. Principles of drug biodisposition in the neonate: a critical evaluation of the pharmacokinetic-pharmacodynamic interface (part II). Clinical Pharmacokinetics 14: 261–286, 1988b
Boreus LO. Pharmacokinetics in children. In Boreus (Ed.) Principles of pediatric pharmacology, pp. 135–139. Churchill Livingstone. New York. 1982
Borofsky LG, Louis S, Kute H. Diphenylhydantoin in children: pharmacology and efficacy. Neurology 23: 967–972, 1973
Bory C, Baltassat P, Porthault M, Bethenod M, Frederich A, et al. Biotransformation of theophylline to caffeine in premature newborn. Lancet 2: 1204–1205, 1978
Bory C, Baltassal P, Porthault M, Bethenod M, Frederich A, et al. Metabolism of theophylline to caffeine in premature newborn infants. Journal of Pediatrics 94: 988–993, 1979
Boutroy M, Vert P, Monin P, Royer RJ, Royer-Morrot MJ. Methylation of theophylline to caffeine in premature infants. Lancet 1: 830, 1979a
Boutroy MJ, Vert P, Royer RJ, Monin P, Royer-Morrot MJ. Caffeine, a metabolite of theophylline during the treatment of apnea in the premature infant. Journal of Pediatrics 94: 996–998, 1979b
Bourgeois BF, Dodson WE. Phenytoin elimination in newborns. Neurology 23: 173–178, 1983
Bowers LD, Canafax DM, Singh J, Seifedlin R, Simmons RL, et al. Studies of cyclosporine blood levels: analysis, clinical utility, pharmacokinetics, metabolites, and chronopharmacology. Transplantation Proceedings 18 (Suppl. 5): 137–143, 1986
Carosella L, Di Nardo P, Bernabei R, Cocchi A, Carbonin P. Chronopharmacokinctics of digitalis: circadian variations of beta-methyl-digoxin serum levels after oral administration. In Reinberg & Halberg (Eds) Chronopharmacology. pp. 125–134, Pergamon Press, Oxford. 1979
Clench J, Reinberg A, Dziewanowska Z, Ghata J, Smolensky M. Circadian changes in 1he bioavailability and effects of indomethacin in healthy subjects. European Journal of Clinical Pharmacology 20: 359–369, 1981
Conley SB, Rechner SM, Rose G, van Buren CT, Brewer E, et al. Use of cyclosporine in pediatric renal transplant recipients. Journal of Pediatrics 106: 45–49, 1985
Craft JC, Holt EA, Tan SH. Malabsorption of oral antibiotics in humans and rats with giardiases. Pediatric Infectious Disease Journal 6: 832–836, 1987
Decousus HA, Croze M, Levi FA, Jaubert JG, Perpoint BM, et al. Circardian changes in anticoagulant effect on heparin infused at a constant rate. British Medical Journal 290: 341–344, 1985
Descorps-Declere A, Bonnafous M, Reinberg A, Begon C. Sex-related differences in diurnal and seasonal changes in effectiveness of pancuronium bromide in man. Chronobiologia 10: 121–122, 1983
Dettli L, Spring P. Diurnal variations in the elimination rate of a sulfonamide in man. Helvetica Medica Acta (Basel) 4: 291–306, 1966
Di Santo A, Chodos D, Halberg F. Chronobioavailability of three erythromycin test preparations assessed by each of four indices: time to peak, peak, nadir and area. Chronobiologia 2(Suppl. 1): 17, 1975
Dreifuss FE, Santilli N, Langer DH, Sweeney KP, Moline KA, et al. Valproic acid hepatic fatalities: a retrospective review. Neurology 37: 379–385, 1987
Dvorchik BH, Vessell ES. Significance of error associated with use of the one compartment formula to calculate clearance of thirty-eight drugs. Clinical Pharmacology and Therapeutics 23: 617–623, 1978
Eadie MJ, Hooper WD, Dickinson RG. Valproate-associaled hepatotoxicity and its biochemical mechanisms. Medical Toxicology 3: 85–106, 1988
English J, Dunne M, Marks V. Diurnal variation in prednisolone kinetics. Clinical Pharmacology and Therapeutics 33: 381–385, 1983
Evans WE, Taylor RH, Feldman S, Crom WR, Rivera G, el al. A model for dosing gentamicin in children and adolescents that adjusts for tissue accumulation with continuous dosing. Clinical Pharmacokinetics 5: 295–306, 1980
Fell PJ, Stevens MT. Pharmacokinetics — uses and abuses. European Journal of Clinical Pharmacology 8: 241–248, 1975
Gal P, Boer HR, Toback J, Wells TJ, Erkan NV. Effect of asphyxia on theophylline clearance in newborns. Southern Medical Journal 75: 836–838, 1982
Gal P, Kandrotas RJ. Sampling frequency to describe drug disposition in neonates. Journal of Pediatrics 112: 1048–1049, 1987
Gal P, Toback J, Erkan NV, Boer HR. The influence of asphyxia on phenobarbital dosing requirements in neonates. Developmental Pharmacology and Therapeutics 7: 145–152, 1984
Garretson LK, Jusko WJ. Diphenylhydantoin elimination kinetics in overdosed children. Clinical Pharmacology and Therapeutics 17: 481–491, 1975
Gaultier C, Reinberg A, Girard F. Circadian rhythms in lung resistance and dynamic lung compliance of healthy children. Effects of two bronchodilators. Respiratory Physiology 31: 169–182, 1977
Geary DF, Thorner P, Baumal R, Major M, Arbus G. Cyclosporin A in children with persistent renal transplant rejection and progressively deteriorating graft function. Pediatric Nephrology 1: 140–144, 1987
Gilman JT, Duchowny MS, Resnick TJ, Hershorin ER. Carbamazepine malabsorption: a case report. Pediatrics 82: 518–519, 1988
Gilman JT, Gal P, Duchowny MS, Weaver RL, Ransom JL. Rapid sequential phenobarbital treatment of neonatal seizures. Pediatrics 83: 674–678, 1989
Gilman JT, Gal P, Levine RS, Hersh CB, Erkan NV. Factors influencing theophylline disposition in 179 newborns. Therapeutic Drug Monitoring 8: 4–10, 1986
Gilman ME, Toback JW, Gal P, Erkan NV. Individualizing phenobarbital dosing in neonates. Clinical Pharmacy 2: 258–262, 1983
Gladtke E. Pharmacokinetics in relation to age. Bollettino Chimico Farmaceutico 112: 333–341, 1973
Gould T, Roberts RJ. Therapeutic problems arising from the use of intravenous route for drug administration. Journal of Pediatrics 95: 465–471, 1979
Grand RJ, Watkins JB, Torti FM. Development of the human gastrointestinal tract: a review. Gastroenterology 70: 790–810, 1976
Grant SD, Forsham PH, Di Raimondo VC. Suppression of 17-hydroxycorticosteroids in plasma and urine after single and divided doses of triamcinolone. New England Journal of Medicine 273: 1115–1118, 1965
Green TP, Mirkin BL. Clinical pharmacokinetics: pediatric considerations. In Benet et al. (Eds) Pharmacokinetic basis for drug treatment, pp. 269–282. Raven Press, New York, 1984
Grygiel JJ, Birkett DJ. Effect of age on patterns of theophylline metabolism. Clinical Pharmacology and Therapeutics 28: 456–462, 1980
Hallek M, Arbogast B, Hellbrugge T, Schmid R, Arbogast H, et al. Circadian dysrhythmia in the behavior of epileptic children with clonazepam and/or phenobarbital treatment. Annual Review of Chronopharmacology 1: 37–40, 1984
Hayes CJ, Butler VP, Gersony WM. Serum digoxin studies in infants and children. Pediatrics 52: 561–568, 1973
Hicks JM, Brett EM. Falsely increased digoxin concentrations in samples from neonates and infants. Therapeutic Drug Monitoring 6: 461–464, 1984
Houghton GW, Richens A, Toseland PA, Davidson S, Falconer MA. Brain concentrations of phenytoin, phenobarbitone, and primidone in epileptic patients. European Journal of Clinical Pharmacology 9: 73–78, 1975
Hrushesky W, Levi F, Kennedy BJ. Cis-diammine-dichloroplatinum (DDP) toxicity to the human kidney reduced by circadian timing. Proceedings of the American Society for Clinical Oncology 21: C45, 1980
Hughes A, Jacabon HJ, Wagner RK, Jungblut PW. Ovarian independent fluctuations of estradiol receptor levels in mammalian tissues. Molecular and Cellular Endocrinology 5: 379–388, 1976
Kauffman RE. Effective and efficient use of drug level measurements to guide medication dosing. Pediatric Annals 14: 332–339, 1985
Kearns GL, Reed MD. Clinical pharmacokinetics in infants and children: a reappraisal. Clinical Pharmacokinetics 17 (Suppl. 1): 29–67, 1989
Kerlin P, Zinsmeister A, Phillips S. Relationship of motility to flow of contents in the human small intestine. Gastroenterology 82: 701–706, 1982
Krauer B. The development of diurnal variation in drug kinetics in the human infants. In Morselli et al. (Eds) Basic and therapeutic aspects of perinatal pharmacology, pp. 347–356, Raven Press, New York. 1975
Krauer B, Spring P, Dettli L. Zur Pharmacokinetik der Sulfonamide im ersten Lebensjahr. Pharmacologia Clinica (Berlin) 1: 47–53, 1968
Lambinet I, Aymard N, Soulairac A, Reinberg A. Chronoptimization of lithium administration in five manic depressive patients: reduction of nephrotoxicity. International Journal of Chronobiology 7: 81, 1981
Law CM, Marchant JL, Honour JW, Preece MA, Warner JO. Nocturnal adrenal suppression in asthmatic children taking inhaled beclomethasone dipropionate. Lancet 1: 942–944, 1986
Leppik IE, Fisher J, Kriel R, Sawchuk RJ. Altered phenytoin clearance with febrile illness. Neurology 36: 1367–1370, 1986
Leung AK. Cutaneous nodule resulting from blood-letting in neonates. European Journal of Pediatrics 145: 579–580, 1986
Levy AM, Leaman DM, Hanson JS. Effects of digoxin on systolic time intervals of neonates and infants. Circulation 46: 816–823, 1972
Loiseau P, Cenraud B, Levy RH, Akbaraly R, Brachet-Liermain A, et al. Diurnal variations in steady-state plasma concentrations of valproic acid in epileptic patients. Clinical Pharmacokinetics 7: 544–552, 1982
Long D, Koren G, James A. Ethics of drug studies in infants: how many samples are required for accurate estimation of pharmacokinetic parameters in neonates? Journal of Pediatrics 111: 918–921, 1987
Macleod SM. Clinical pharmacokinetics: a pediatric overview. In Macleod & Radde (Eds) Textbook of pediatric clinical pharmacology, pp. 106–111, PSG Publishing, Littleton. 1985
Markiewicz A, Semenowicz K. Time dependent changes in the pharmacokinetics of aspirin. International Journal of Clinical Pharmacology and Biopharmacy 17: 409–411, 1979
Markiewicz A, Semenowicz K, Korczynska J, Boldys H. Temporal variations in the response of ventilatory and circulatory functions to propranolol in healthy man. In Smolensky et al. (Eds) Recent advances in the chronobiology of allergy and immunology, pp. 185–193. Pergamon Press, Oxford, 1980
Martin BK. Treatment of data from drug urinary excretion. Nature 214: 247–249, 1967
Milsap RL, Szefler SJ. Special pharmacokinetic considerations in children. In Evans et al. (Eds) Applied pharmacokinetics: principles of therapeutic drug monitoring. 2nd ed., pp. 294–330, Applied Therapeutics, Spokane, 1986
Minors DS, Waterhouse JM. Aspects of chronopharmacokinetics and chronergy of ethanol in healthy man. Chronobiologia 7: 465–480, 1979
Moeller H. Chronopharmacology of hydrocortisone and 9 fluorohydrocortisone in the treatment of congenital adrenal hyperplasia. European Journal of Pediatrics 144: 370–373, 1985
Moore-Ede MC, Meguid MM, Fitzpatrick CF, Boyden CM, Ball MR. Circadian variation in response to potassium infusion. Clinical Pharmacology and Therapeutics 23: 218–227, 1978
Morselli PL. Development of physiological variables important for drug kinetics. In Morselli et al. (Eds) Antiepileptic drug therapy in pediatrics, pp. 1–12. Raven Press, New York, 1983
Morselli PL, Franco-Morselli R, Bossi L. Clinical pharmacokinetics in newborns and infants: age related differences and therapeutic implications. Clinical Pharmacokinetics 5: 485–527, 1980
Muttitt SC, Tierney AJ, Finer NN. The dose response of theophylline in the treatment of apnea of prematurity. Journal of Pediatrics 112: 115–121, 1988
Nahata MC. Influence of infusion methods on therapeutic drug monitoring in pediatric patients. Drug Intelligence and Clinical Pharmacy 20: 367–369, 1986
Nahata MC, Powell DA, Franko TG. Some infants receiving theophylline may have caffeine in serum. Therapeutic Drug Monitoring 5: 269–270, 1983
Nassif EG, Weinberger MM, Shannon D, Guiang SF, Hendeles L, et al. Theophylline disposition in infancy. Journal of Pediatrics 98: 158–161, 1981
Nelson JD, Shcllon S, Kusmiesz HT, Haltalin KC. Absorption of ampicillin and nalidixic acid by infants and children with acute shigellosis. Clinical Pharmacology and Therapeutics 13: 879–886, 1972
Onishi S, Yoshihi O, Nishimura Y, Itoh S, Isobc K, et al. Distribution of phenobarbital in serum, brain and other organs from pedialric patients. Developmental Pharmacology and Therapeutics 7: 153–159, 1984
Painter MJ, Pippcngcr C, MacDonald H, Pitlick W. Phenobarbital and diphenylhydantoin levels in neonates with seizures. Journal of Pediatrics 92: 315–319, 1978
Painter MJ, Pippenger CE, Wasterlein C, Barmada M, Pitlick W, et al. Phenobarbital and phenytoin in neonatal seizures: metabolism and tissue distribution. Neurology 31: 1107–1112, 1981
Paxton JW, Aman MG, Werry JS. Fluctuation in salivary carbamazepine and carbamazepine-10, 11-epoxide concentrations during the day in epileptic children. Epilepsia 24: 716–724, 1983
Pearlman SA, Duran C, Wood MA, Maisels MJ, Berlin CM. Caffeine pharmacokinetics in preterm infants older than 2 weeks. Developmental Pharmacology and Therapeutics 12: 65–69, 1989
Petit E, Milano G, Levi F, Thyss A, Bailleul F, et al. Circadian rhythm-varying plasma concentration of 5-fluorouracil during a five-day continuous venous infusion at a constant rate in cancer patients. Cancer Research 48: 1676–1679, 1988
Phelps SJ, Kamper CA, Bottorff MB, Alpert BS. Effect of age and serum creatinine on endogenous digoxin-like substances in infants and children. Journal of Pediatrics 110: 136–139, 1987
Pinkerton CR, Welshman SG, Glasgow JF, Bridges JM. Can food influence the absorption of methotrexate in children with acute lymphoblastic leukemia? Lancet 2: 944–946, 1980
Pippenger CE. Maturation of biotransformation rates. In Morselli et al. (Eds) Antiepileptic drug therapy in pediatrics, pp. 333–338. Raven Press. New York. 1984
Pitlick W, Painter M, Pippenger C. Phenobarbital pharmacokinetics in neonates. Clinical Pharmacology and Therapeutics 23: 346–350, 1978
Pollmann L. Étude de la chronobiologie des dents. Revue de Stomatologie et de Chirurgie Maxillo-Faciale 82: 201, 1981
Prandota J. Clinical pharmacokinetics of changes in drug elimination in children. Developmental Pharmacology and Therapeutics 8: 311–328, 1985
Pudek MR, Seecombe DW, Whitfield MF, Ling E. Digoxin-like immunoreactivity in premature and full-term infants not receiving digoxin therapy. New England Journal of Medicine 308: 904, 1983
Rane A. Basic principles of drug disposition and action in infants and children. In Yaffe (Ed.) Pediatric pharmacology: therapeutic principles in practice, pp. 7–28. Grune and Stratton, New York. 1980
Rane A. Changes in drug metabolism during child growth. In Lemberger & Reidenberg (Eds) Proceedings of the second world conference on clinical pharmacology and therapeutics, pp. 861–867. American Society for Pharmacology and Experimental Therapeutics, Bethesda, 1984
Rane A. Wilson JT. Clinical pharmacokinetics in infants and children. Clinical Pharmacokinetics 1: 2–24, 1976
Reinberg A. Circadian rhythms in effects of hypnotics and sleep inducers. International Journal of Clinical Pharmacology Research 6: 33–44, 1986
Reinberg A, Briere L, Fraboulet G, Guillamant S, Touitou Y, et al. Clinical chronopharmacology of ACTH 1-17. III: effects on fatigue, oral temperature, heart rate, grip strength and bronchial patency. Chronobiologia 8: 101–115, 1981
Reinberg A, Halberg F, Falliers C. Circadian timing of methyl-prednisolone effects in asthmatic boys. Chronobiologia 1: 333–347, 1974
Reinberg A, Levi F, Guillet P, Burke JT, Nicolai A. Chronopharmacological study of antihistamines in man with special reference to terfenadine. European Journal of Clinical Pharmacology 14: 245–252, 1978
Reinberg A, Reinberg M. Circadian changes of the duration of action of local anaesthetic agents. Naunyn-Schmiedeberg’s Archives of Pharmacology 297: 149–152, 1977
Reinberg A, Smolensky MH. Circadian changes of drug disposition in man. Clinical Pharmacokinetics 7: 401–420, 1982
Reinberg A, Zagula-Mally Z, Ghata J, Halberg F. Circadian rhythms in duration of salicylate excretion referred to phase of excretory rhythms and routine. Proceedings of the Society for Experimental Biology 124: 826–832, 1967
Riva R, Albani F, Cortelli P, Gobbi G, Perucca E, et al. Diurnal fluctuations in free and total plasma concentrations of valproic acid at steady state in epileptic patients. Therapeutic Drug Monitoring 5: 191–196, 1983
Roberts RJ. Intravenous administration of medication in pediatric patients: problems and solutions. Pediatric Clinics of North America 28: 23–34, 1981
Roberts RJ. Special considerations in drug therapy in infants. In Roberts (Ed.) Drug therapy in infants: pharmacologic principles and clinical experience, pp. 25–35, W.B. Saunders. Philadelphia. 1984
Rogers RJ, Kalisker A, Wiener MB, Szefler SJ. Inconsistent absorption from a sustained-release theophylline preparation during continuous therapy in asthmatic children. Journal of Pediatrics 106: 496–501, 1985
Salmon R, Accary JP, Descorps-Declere A, Reinberg A. Circadian variation of blood gastrin in a case of short bowel syndrome: effects of intravenous nutrition and cimetidine. International Journal of Chronobiology 7: 306, 1981
Scalabrino R, Pasquariello G. Osservazioni pratiche in tema di ritmo dell’ attività corticosurrenalica. Reumatismo 19: 81, 1967
Scheffner D, Konig S, Rauterberg-Rulannd I, Kochen W, Hofmann WJ, et al. Fatal liver failure in 16 children with valproate therapy. Epilepsia 29: 530–542, 1988
Schulz F, Rctiene K. Experimental results in animals and clinical findings with corticosteroid therapy at various intervals. Klinische Wochenschrift 49: 100–105, 1971
Shannon DC, Gotay F, Stein IM, Rogers MC, Todres ID, et al. Prevention of apnea and bradycardia in low-birthweight infants. Pediatrics 55: 589–594, 1975
Sharma DS, Deshpande VA, Samuel MR, Vakil BJ. Chronobio-availability of ampicillin. Chronobiologia 6: 156, 1979
Sherwin AL, Eisen AA, Sokolowski CD. Anticonvulsant drugs in human epileptogenic brain. Archives of Neurology 29: 73–77, 1973
Shively CA, Simons RJ, Passananti GT, Dvorchik BH, Vesell ES. Dietary patterns and diurnal variations in aminopyrine disposition. Clinical Pharmacology and Therapeutics 29: 65–73, 1981
Shively CA, Vesell ES. Temporal variations in acetaminophen and phenacetin half-life in man. Clinical Pharmacology and Therapeutics 18: 413–424, 1975
Smolensky MH, Scott PH, Kramer WG. Clinical significance of day-night differences in serum theophylline concentration with special reference to Theo-Dur®. Journal of Allergy and Clinical Immunology 78: 716–722, 1986
So S, Najarian JS, Nevins TE, Fryd DS, Knaak M, et al. Low-dose cyclosporine therapy combined with standard immuno-suppression in pediatric renal transplantation. Journal of Pediatrics 111: 1017–1021, 1987
Sothern RB, Halberg F, Hrushesky, W, Doe R. Circadian optimizalion on cis-diammine dichloroplatinum (Pt) and adriamycin (Ad) combination (Pt-Ad) therapy of an immunocytoma gauged by complete remission or cure. Clinical Research 26: 712, 1978
Stewart CF, Hampton EM. Effect of maturation on drug disposition in pediatric patients. Clinical Pharmacy 6: 548–564, 1987
Tarquini B, Romano S, deScalzi M, deLeonardis V, Benvenuli F, et al. Circadian variations of iron absorption in healthy human subjects. In Reinberg & Halberg (Eds) Chronopharmacology. pp. 347–354, Pergamon Press. Oxford. 1979
Triggs EJ, Hopper WD, Dickinson RG. The influence of age on drug metabolism. Medical Journal of Australia 22: 823–827, 1984
Tserng KY, Takieddine FN, King KC. Developmental aspects of theophylline metabolism in premature infants. Clinical Pharmacology and Therapeutics 33: 522–528, 1983
Valdes R, Graves SW, Brown BA, Landt M. Endogenous substance in newborn infants causing false positive digoxin measurements. Journal of Pediatrics 102: 947–950, 1983
Wilkinson GR. Clinical pharmacokinetics in pediatrics. In Mirkin (Ed.) Clinical pharmacology and therapeutics, pp. 61–71. Year Book. Chicago 1978
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gilman, J.T. Therapeutic Drug Monitoring in the Neonate and Paediatric Age Group. Clin Pharmacokinet 19, 1–10 (1990). https://doi.org/10.2165/00003088-199019010-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003088-199019010-00001